ChARM aims to be the leading company in diagnosing pneumonia in children under 5 in low-resource settings

ChARM will solve the unmet need by enabling frontline health workers to correctly diagnose pneumonia with children < 5y to make simple treatment with low-cost medicine possible. The ambition is to save 100's of 1000 children from dying, positively impact million children's health, and to fight Anti Microbial Resistance